Bioactivity:

Imeglimin is the first in a new tetrahydrotriazine-containing class of oral antidiabetic agents. It has been shown to act on the liver, muscle, and pancreatic _-cells to uniquely target the key defects of type 2 diabetes.

CAS nr:

775351-65-0

Purity:

98%

Molecular Weight:

155,2

SMILES:

CC1N=C(NC(=N1)N(C)C)N

Formula:

C6H13N5

Pathway:

Others

Target:

Others